AI in clinical research: realistic use cases in 2026
What AI does and doesn't do in a modern EDC. 5 use cases with real value for clinical researchers.
Trialinx
Trialinx editorial team
No hype
AI in clinical research is full of exaggerated promises. This post focuses on cases where AI creates real value today — with human-in-the-loop — not on what-ifs.
1. CRF generation from protocol
Upload the protocol (PDF or text). AI produces a draft of 3-5 forms with appropriate fields, validations, and basic conditional logic. You review and adjust.
Realistic savings: 60-80% of initial layout time.
What it does NOT do: decide which variables to collect. That's still yours.
2. Statistical analysis suggestion
Describe your hypothesis and variable types (dichotomous vs continuous, paired vs unpaired). AI suggests which test to apply and explains assumptions and requirements.
Realistic savings: avoids common errors (t-test where Mann-Whitney should go).
What it does NOT do: make the decision for you. Interpretation and signature remain yours.
3. Natural language data exploration
Ask "how many subjects over 65 with diabetes had the primary outcome" and AI translates to a structured query.
Realistic savings: removes the friction of learning the query builder.
What it does NOT do: confirmatory analyses. This is for descriptive exploration.
4. Automatic data summary
Dashboard auto-generated with KPIs relevant to the study design (recruitment, adherence, pending queries). Refreshes periodically.
Realistic savings: visibility without depending on IT.
What it does NOT do: replace protocol-defined analysis. It's operational dashboard, not final analysis.
5. Query resolution assistance
Suggests resolutions for common queries (out-of-range values, cross-field inconsistencies) based on patterns in the study itself. Monitor reviews and accepts or rejects.
Realistic savings: 30-50% of monitor time.
What it does NOT do: make clinical decisions. Judgment stays with monitor and investigator.
What you should NOT ask AI
- Diagnose the subject.
- Decide whether an event is SAE.
- Sign or randomize.
- Publish forms without human review.
- Interpret results for publication.
All of these require named human responsibility. Not delegable.
Privacy and re-training
Trialinx uses zero-retention, no-retraining models to process clinical data. This means the model provider does not store PHI prompts or use them to train future models.
Always ask your EDC provider for a specific DPA about AI use with clinical data.
Conclusion
AI is productive when drafting, suggesting, and exploring. It stops being when deciding. The investigator remains responsible. Compliance remains shared. And data integrity stays sacred.
Want to try Trialinx?
Free plan with 1 study, 15 forms, and 10 subjects. No credit card.
Related articles
Electronic Signatures in Clinical Trials: 21 CFR Part 11 Explained
A practical guide to electronic signatures in clinical trials and 21 CFR Part 11, covering signer identity, timestamps, signature meaning, record linking, audit trails, SOPs, and Trialinx signature-event evidence.
Clinical Trial Software for Small Research Teams: What Actually Matters
A practical framework for small clinical research teams comparing clinical trial software, with CRFs, subject tracking, roles, audit trails, exports, AI, and pricing.
5 Clinical Trial Data Collection Mistakes Small Teams Keep Repeating
A practical guide to five clinical trial data collection mistakes small teams make, and how to prevent bad data, rework, and painful exports.